Andrew S. Giraud
- Immunology top 2%
- Galectins and Cancer Biology 13
- IL-33, ST2, and ILC Pathways 8
- Oncology top 2%
- Cytokine Signaling Pathways and Interactions 11
- Surgery top 2%
- Helicobacter pylori-related gastroenterology studies 43
- Eosinophilic Esophagitis 6
- Gastroenterology top 5%
- Cancer Research top 5%
-
- Neuropeptides and Animal Physiology 13
-
- Digestive system and related health 9
-
- Cancer-related gene regulation 9
- Co-authors
- Louise M. JuddTrevelyan R. MenheniottMatthias ErnstBrendan J. JenkinsNeville D. YeomansBarbara M. AldermanDianne GrailTimothy C. Wang
- Cited by
- ImmunologyOncologySurgery
- Journals
- Journal of Biological Chemistry (1 paper)Journal of Clinical Investigation (1 paper)Nature Medicine (2 papers)
- Partner nations
- AustraliaUnited StatesJapan
In The Last Decade
Andrew S. Giraud
90 papers receiving 3.3k citations
Peers
Comparison fields: 5 of 110
- Immunology 1.1k
- Oncology 1.1k
- Surgery 1.3k
- Gastroenterology 158
- Cancer Research 398
Countries citing papers authored by Andrew S. Giraud
This map shows the geographic impact of Andrew S. Giraud's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew S. Giraud with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew S. Giraud more than expected).
Fields of papers citing papers by Andrew S. Giraud
This network shows the impact of papers produced by Andrew S. Giraud. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew S. Giraud. The network helps show where Andrew S. Giraud may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Andrew S. Giraud, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 89 | |
| 2 | 2015 | 79 | |
| 3 | 2015 | 3 | |
| 4 | Lineage-specific RUNX3 hypomethylation marks the preneoplastic immune component of gastric cancer | 2014 | 1 |
| 5 | 2014 | 3 | |
| 6 | 2012 | 22 | |
| 7 | 2011 | 52 | |
| 8 | 2008 | 13 | |
| 9 | 2004 | 15 | |
| 10 | 2004 | 28 | |
| 11 | 2003 | 10 | |
| 12 | 2002 | 392 | |
| 13 | 2001 | 1 | |
| 14 | 2001 | 17 | |
| 15 | Lessons from genetically engineered animal models X. Trefoil peptide and EGF receptor/ligand transgenic mice. | 2000 | 9 |
| 16 | 2000 | 1 | |
| 17 | 1998 | 21 | |
| 18 | 1998 | 38 | |
| 19 | 1997 | 10 | |
| 20 | 1996 | 14 |
About Andrew S. Giraud
Andrew S. Giraud is a scholar working on Immunology, Surgery and Gastroenterology, having authored 90 papers that have together received 3.3k indexed citations. Recurring topics across this work include Helicobacter pylori-related gastroenterology studies (43 papers), Galectins and Cancer Biology (13 papers), Neuropeptides and Animal Physiology (13 papers), Cytokine Signaling Pathways and Interactions (11 papers), Digestive system and related health (9 papers), Cancer-related gene regulation (9 papers), IL-33, ST2, and ILC Pathways (8 papers) and Eosinophilic Esophagitis (6 papers). The work is most often cited by research in Immunology (1.1k citations), Oncology (1.1k citations) and Surgery (1.3k citations). Andrew S. Giraud has collaborated with scholars based in Australia, United States and Japan. Frequent co-authors include Louise M. Judd, Trevelyan R. Menheniott, Matthias Ernst, Brendan J. Jenkins, Neville D. Yeomans, Barbara M. Alderman, Dianne Grail, Timothy C. Wang, Anastasia Kalantzis and Meegan Howlett. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Nature Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.